NeuroBooster Array: A Genome-Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations
Sara Bandrés‐Ciga(National Institutes of Health), Dan Vitale(National Institutes of Health), Derek P. Narendra(National Institutes of Health), Armando Reyes‐Palomares(Universidad Complutense de Madrid), Steven Lubbe(Northwestern University), Kristin Levine(National Institutes of Health), John Hardy(Queen Mary University of London), Christine Klein(University of Lübeck), Peter Wild Crea(National Institutes of Health), Hampton L. Leonard(National Institutes of Health), Paula Saffie Awad(Universidade Federal do Rio Grande do Sul), Bryan J. Traynor(National Institutes of Health), Edwin Jabbari(King's College London), Mathew J. Koretsky(National Institutes of Health), Mary B. Makarious(National Institutes of Health), Sonja W. Scholz(School of the Art Institute of Chicago), Sonya B. Dumanis(Research Network (United States)), Faraz Faghri(National Institute of Neurological Disorders and Stroke), John P. Quinn(Queen's University Belfast), Ekemini Riley(Research Network (United States)), Claudia Schulte(School of the Art Institute of Chicago), Elisa Majounie, Cornelis Blauwendraat(National Institutes of Health), Huw R. Morris(University College London), Henry Houlden(University College London), Hirotaka Iwaki(National Institute of Neurological Disorders and Stroke), Andrew Singleton(Laboratory of Molecular Genetics), Dena Hernández(Framingham Heart Study), Janina M. Jeff, Sampath Arepalli(National Institutes of Health), Mike A. Nalls(Alzheimer's Association), Kimberley J. Billingsley(National Institutes of Health), Jeffrey Kim(National Institutes of Health), Katja Lohmann(University of Lübeck)
Cited by 23
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k